Medical Criteria for Evaluating Cystic Fibrosis, 26681 [2013-10702]

Download as PDF tkelley on DSK3SPTVN1PROD with NOTICES Federal Register / Vol. 78, No. 88 / Tuesday, May 7, 2013 / Notices docket number SBA–2013–0004, by any of the following methods: • Federal eRulemaking Portal: http:// www.regulations.gov. Follow the instructions for submitting comments. • Mail/Hand Delivery/Courier: Edward Halstead, Procurement Analyst, U.S. Small Business Administration, 409 3rd Street SW., 8th floor, Washington, DC 20416. All comments will be posted on www.Regulations.gov. If you wish to include within your comment confidential business information (CBI) as defined in the Privacy and Use Notice/User Notice at www.Regulations.gov and you do not want that information disclosed, you must submit the comment by either Mail or Hand Delivery. In the submission, you must highlight the information that you consider is CBI and explain why you believe this information should be withheld as confidential. SBA will make a final determination, in its sole discretion, as to whether the information is CBI and therefore will be published or withheld. FOR FURTHER INFORMATION CONTACT: Edward Halstead, (202) 205–9885, Edward.halstead@sba.gov. SUPPLEMENTARY INFORMATION: Section 8(a)(17) of the Small Business Act (the Act), 15 U.S.C. 637(a)(17), and SBA’s implementing regulations generally require that recipients of Federal supply contracts that are set aside for small businesses, Small Disabled Veteran Owned Small Business Concerns, Women-Owned Small Businesses, or Participants in the SBA’s 8(a) Business Development Program provide the product of a domestic small business manufacturer or processor if the recipient is other than the actual manufacturer or processor of the product. This requirement is commonly referred to as the Nonmanufacturer Rule. 13 CFR 121.406(b). The Act authorizes SBA to waive the Nonmanufacturer Rule for any ‘‘class of products’’ for which there are no small business manufacturers or processors available to participate in the Federal market. In order to be considered available to participate in the Federal market for a class of products, a small business manufacturer must have submitted a proposal for a contract or received a contract from the Federal government within the last 24 months. 13 CFR 121.1202(c). SBA defines ‘‘class of products’’ as an individual subdivision within a North American Industry Classification System (NAICS) Industry Number as established by the Office of Management and Budget in the NAICS Manual. 13 CFR 121.1202(d). In VerDate Mar<15>2010 15:24 May 06, 2013 Jkt 229001 addition, SBA uses Product Service Codes (PSCs) to further identify particular products within the NAICS code to which a waiver would apply. SBA may then identify a specific item within a PSC and NAICS code to which a class waiver would apply. On April 4, 2013, SBA published a notice in the Federal Register announcing that SBA was considering rescinding a class waiver of the Nonmanufacturer Rule for Aerospace Ball and Roller Bearings, NAICS code 332991, PSC 3110, based on information submitted by several small business manufacturers of aerospace ball and roller bearings that have done business with the Federal government within the previous two years. 78 FR 20371. The public comment period for the notice to rescind the class waiver for Aerospace Ball and Roller Bearings was to close on May 4, 2013. This notice announces an extension of the public comment period until June 3, 2013. Kenneth W. Dodds, Director, Office of Government Contracting. [FR Doc. 2013–10812 Filed 5–3–13; 4:15 pm] BILLING CODE 8025–01–P 26681 Social Security Online, at http:// www.socialsecurity.gov. On Friday, May 10, 2013 at 1:00 p.m., EDT, we will conduct an informational briefing on our proposed changes to Listings 3.04 and 103.04 of the Listing of Impairments, as described in the Notice of Proposed Rulemaking we published in the Federal Register on February 4, 2013 (78 FR 7968). We use Listings 3.04 and 103.04 to evaluate claims involving cystic fibrosis in adults and children under titles II and XVI of the Social Security Act. The teleconference is open to the public and we invite interested individuals to call in to listen. The teleconference will be strictly informational. The public comment period for this matter closed on April 5, 2013. We will not be accepting additional public comments. To call in by telephone dial 1–888– 576–4390 and use participant passcode 897116. The moderator of the teleconference will be Arthur R. Spencer, Associate Commissioner for Disability Programs. SUPPLEMENTARY INFORMATION: SOCIAL SECURITY ADMINISTRATION Agenda [Docket No. SSA–2006–0149] 1. General background information on the disability program. 2. Information for individuals with cystic fibrosis who apply for Social Security disability benefits, and for individuals with cystic fibrosis who are currently receiving disability benefits. 3. Information we received from medical experts and members of the public. 4. Proposed criteria in listings 3.04 and 103.04. A final agenda will be available at http://www.socialsecurity.gov/ disability/documents/Respiratory%20%20CF%20Teleconference%20%20Agenda%204-30-13.docx. We will post a summary of this teleconference in the rulemaking record at http://www.regulations.gov. Use the Search function of the Web page to find docket number SSA–2006–0149 and look under Supporting & Related Material. RIN 0960–AF58 Medical Criteria for Evaluating Cystic Fibrosis Social Security Administration. Notice of teleconference. AGENCY: ACTION: SUMMARY: On Friday, May 10, 2013 at 1:00 p.m., EDT, we will conduct an informational briefing on our proposed changes to Listings 3.04 and 103.04 of the Listing of Impairments, as described in our recent Notice of Proposed Rulemaking. The teleconference is open to the public and will be strictly informational. We will not be accepting additional public comments. DATES: The teleconference will take place on Friday, May 10, 2013 at 1:00 p.m., EDT. ADDRESSES: For additional information regarding this teleconference, please contact Cheryl Williams, Office of Medical Listings Improvement, Office of Disability Programs, Social Security Administration, 6401 Security Boulevard, Baltimore, Maryland 21235– 6401, (410) 965–1020. For information on eligibility or filing for benefits, call our national toll-free number, 1–800–772–1213, or TTY 1– 800–325–0778, or visit our Internet site, PO 00000 Frm 00071 Fmt 4703 Sfmt 9990 Dated: May 1, 2013. Arthur R. Spencer, Associate Commissioner, Office of Disability Programs. [FR Doc. 2013–10702 Filed 5–6–13; 8:45 am] BILLING CODE 4191–02–P E:\FR\FM\07MYN1.SGM 07MYN1

Agencies

[Federal Register Volume 78, Number 88 (Tuesday, May 7, 2013)]
[Notices]
[Page 26681]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-10702]


=======================================================================
-----------------------------------------------------------------------

SOCIAL SECURITY ADMINISTRATION

[Docket No. SSA-2006-0149]
RIN 0960-AF58


Medical Criteria for Evaluating Cystic Fibrosis

AGENCY: Social Security Administration.

ACTION: Notice of teleconference.

-----------------------------------------------------------------------

SUMMARY: On Friday, May 10, 2013 at 1:00 p.m., EDT, we will conduct an 
informational briefing on our proposed changes to Listings 3.04 and 
103.04 of the Listing of Impairments, as described in our recent Notice 
of Proposed Rulemaking. The teleconference is open to the public and 
will be strictly informational. We will not be accepting additional 
public comments.

DATES: The teleconference will take place on Friday, May 10, 2013 at 
1:00 p.m., EDT.

ADDRESSES: For additional information regarding this teleconference, 
please contact Cheryl Williams, Office of Medical Listings Improvement, 
Office of Disability Programs, Social Security Administration, 6401 
Security Boulevard, Baltimore, Maryland 21235-6401, (410) 965-1020.
    For information on eligibility or filing for benefits, call our 
national toll-free number, 1-800-772-1213, or TTY 1-800-325-0778, or 
visit our Internet site, Social Security Online, at http://www.socialsecurity.gov.

SUPPLEMENTARY INFORMATION: On Friday, May 10, 2013 at 1:00 p.m., EDT, 
we will conduct an informational briefing on our proposed changes to 
Listings 3.04 and 103.04 of the Listing of Impairments, as described in 
the Notice of Proposed Rulemaking we published in the Federal Register 
on February 4, 2013 (78 FR 7968). We use Listings 3.04 and 103.04 to 
evaluate claims involving cystic fibrosis in adults and children under 
titles II and XVI of the Social Security Act.
    The teleconference is open to the public and we invite interested 
individuals to call in to listen. The teleconference will be strictly 
informational. The public comment period for this matter closed on 
April 5, 2013. We will not be accepting additional public comments.
    To call in by telephone dial 1-888-576-4390 and use participant 
passcode 897116. The moderator of the teleconference will be Arthur R. 
Spencer, Associate Commissioner for Disability Programs.

Agenda

    1. General background information on the disability program.
    2. Information for individuals with cystic fibrosis who apply for 
Social Security disability benefits, and for individuals with cystic 
fibrosis who are currently receiving disability benefits.
    3. Information we received from medical experts and members of the 
public.
    4. Proposed criteria in listings 3.04 and 103.04.
    A final agenda will be available at http://www.socialsecurity.gov/disability/documents/Respiratory%20-%20CF%20Teleconference%20-%20Agenda%204-30-13.docx.
    We will post a summary of this teleconference in the rulemaking 
record at http://www.regulations.gov. Use the Search function of the 
Web page to find docket number SSA-2006-0149 and look under Supporting 
& Related Material.

    Dated: May 1, 2013.
Arthur R. Spencer,
Associate Commissioner, Office of Disability Programs.
[FR Doc. 2013-10702 Filed 5-6-13; 8:45 am]
BILLING CODE 4191-02-P